|
US6245769B1
(en)
*
|
1997-09-02 |
2001-06-12 |
Dupont Pharmaceuticals Company |
Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disorders
|
|
US6040315A
(en)
*
|
1997-10-30 |
2000-03-21 |
Day; Charles E. |
Antacid co-polymer of guanidine and polyethylenimine
|
|
DE19844291A1
(de)
*
|
1998-09-18 |
2000-03-23 |
Schering Ag |
Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln
|
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
|
US6495558B1
(en)
|
1999-01-22 |
2002-12-17 |
Amgen Inc. |
Kinase inhibitors
|
|
CA2359680A1
(en)
*
|
1999-01-22 |
2000-07-27 |
David M. Armistead |
Kinase inhibitors
|
|
DK1057831T3
(da)
|
1999-05-26 |
2005-01-31 |
Hoffmann La Roche |
Fremgangsmåde til fremstilling af vinylpyrimidinderivater
|
|
JP2004500333A
(ja)
*
|
1999-07-30 |
2004-01-08 |
ファーマジーン ラボラトリーズ リミテッド |
胃腸管障害の治療における、２−アミノ−４−（４−フルオロナフタ−１−イル）−６−イソプロピルピリミジンの使用
|
|
GB9919778D0
(en)
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
|
AU779908B2
(en)
|
1999-09-10 |
2005-02-17 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US7101869B2
(en)
|
1999-11-30 |
2006-09-05 |
Pfizer Inc. |
2,4-diaminopyrimidine compounds useful as immunosuppressants
|
|
WO2001062233A2
(en)
*
|
2000-02-25 |
2001-08-30 |
F. Hoffmann La Roche Ag |
Adenosine receptor modulators
|
|
GB0004886D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0004887D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0007371D0
(en)
|
2000-03-28 |
2000-05-17 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0016877D0
(en)
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0021726D0
(en)
|
2000-09-05 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
|
US6444477B1
(en)
|
2000-11-28 |
2002-09-03 |
Pharmagene Laboratories Limited |
Assay method for detecting 5-HT2B antagonists
|
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
|
CN1527710A
(zh)
|
2001-05-14 |
2004-09-08 |
����˹�ж�-����˹˹����ҩƷ��˾ |
作为促肾上腺皮质激素释放因子配体的取代的吡嗪酮、吡啶和嘧啶
|
|
GB0113041D0
(en)
|
2001-05-30 |
2001-07-18 |
Astrazeneca Ab |
Chemical compounds
|
|
CA2450934A1
(en)
*
|
2001-06-19 |
2002-12-27 |
Marco Dodier |
Pyrimidine inhibitors of phosphodiesterase (pde) 7
|
|
US6825198B2
(en)
*
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
|
CA2450562A1
(en)
|
2001-06-22 |
2003-01-03 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
AU2003207299A1
(en)
*
|
2002-02-13 |
2003-09-04 |
Pharmagene Laboratories Limited |
5-ht2b receptor antagonists
|
|
GB0203412D0
(en)
*
|
2002-02-13 |
2002-04-03 |
Pharmagene Lab Ltd |
5-HT 2B receptor antagonists
|
|
GB0205688D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
|
US7442697B2
(en)
|
2002-03-09 |
2008-10-28 |
Astrazeneca Ab |
4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity
|
|
GB0205693D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0205690D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
|
US20040023981A1
(en)
*
|
2002-07-24 |
2004-02-05 |
Yu Ren |
Salt forms with tyrosine kinase activity
|
|
US20040023978A1
(en)
*
|
2002-07-24 |
2004-02-05 |
Yu Ren |
Active salt forms with tyrosine kinase activity
|
|
US6872724B2
(en)
|
2002-07-24 |
2005-03-29 |
Merck & Co., Inc. |
Polymorphs with tyrosine kinase activity
|
|
HRP20050089B1
(hr)
|
2002-07-29 |
2015-06-19 |
Rigel Pharmaceuticals |
Upotreba 2,4 pirimidindiaminskog spoja za proizvodnju lijeka za lijeäśenje ili sprjeäśavanje autoimunosne bolesti
|
|
US7109337B2
(en)
*
|
2002-12-20 |
2006-09-19 |
Pfizer Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
UA80767C2
(en)
*
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
CA2529611C
(en)
*
|
2002-12-20 |
2009-12-15 |
Pfizer Products Inc. |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
GB0311276D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0311274D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2005012263A1
(en)
*
|
2003-07-24 |
2005-02-10 |
Pharmagene Laboratories Limited |
5-ht2b receptor antagonists
|
|
JP2007500683A
(ja)
*
|
2003-07-25 |
2007-01-18 |
チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド |
抗菌剤としての、置換された２，４−ビス（アルキルアミノ）ピリミジン又は−キナゾリンの使用
|
|
WO2005012294A1
(en)
|
2003-07-30 |
2005-02-10 |
Rigel Pharmaceuticals, Inc. |
2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
|
|
US20070099938A1
(en)
*
|
2003-10-24 |
2007-05-03 |
Ono Pharmaceutical Co., Ltd. |
Antistress drug and medical use thereof
|
|
US20080275062A1
(en)
*
|
2004-01-30 |
2008-11-06 |
David Harold Drewry |
Chemical Compounds
|
|
TW200528101A
(en)
|
2004-02-03 |
2005-09-01 |
Astrazeneca Ab |
Chemical compounds
|
|
JPWO2005079845A1
(ja)
|
2004-02-20 |
2007-08-02 |
アステラス製薬株式会社 |
片頭痛予防薬
|
|
CA2561895A1
(en)
*
|
2004-04-13 |
2005-10-27 |
Icagen, Inc. |
Polycyclic pyrimidines as potassium ion channel modulators
|
|
MXPA06011658A
(es)
*
|
2004-05-14 |
2006-12-14 |
Pfizer Prod Inc |
Derivados de pirimidina para el tratamiento del crecimiento celular anormal.
|
|
JP2007537230A
(ja)
*
|
2004-05-14 |
2007-12-20 |
ファイザー・プロダクツ・インク |
異常細胞増殖の処置用のピリミジン誘導体
|
|
JP2007537238A
(ja)
*
|
2004-05-14 |
2007-12-20 |
ファイザー・プロダクツ・インク |
異常細胞増殖の治療のためのピリミジン誘導体
|
|
US20060205945A1
(en)
*
|
2004-05-14 |
2006-09-14 |
Pfizer Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
CA2581454A1
(en)
*
|
2004-09-23 |
2006-03-30 |
Reddy Us Therapeutics, Inc. |
Novel pyrimidine compounds, process for their preparation and compositions containing them
|
|
ES2371924T3
(es)
*
|
2004-09-30 |
2012-01-11 |
Tibotec Pharmaceuticals |
Pirimidinas 5-carbo o heterociclo- sustituidas que inhiben el hiv.
|
|
GB2420559B
(en)
*
|
2004-11-15 |
2008-08-06 |
Rigel Pharmaceuticals Inc |
Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
|
|
SI1814878T1
(sl)
|
2004-11-24 |
2012-06-29 |
Rigel Pharmaceuticals Inc |
Spojine spiro-2,4-pirimidindiamina in njihova uporaba
|
|
GB0500492D0
(en)
*
|
2005-01-11 |
2005-02-16 |
Cyclacel Ltd |
Compound
|
|
AU2006206458B2
(en)
|
2005-01-19 |
2012-10-25 |
Rigel Pharmaceuticals, Inc. |
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
|
|
ES2533258T3
(es)
*
|
2005-02-18 |
2015-04-08 |
Janssen Sciences Ireland Uc |
Derivados de óxido de 2-(4-cianofenilamino)pirimidina que inhiben el VIH
|
|
CN101151249B
(zh)
*
|
2005-03-31 |
2011-04-06 |
辉瑞产品公司 |
环戊吡啶及四氢喹啉衍生物
|
|
EP1883302A4
(en)
*
|
2005-05-03 |
2009-05-20 |
Rigel Pharmaceuticals Inc |
JAK KINASE HEMMER AND ITS USE
|
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
|
NZ564222A
(en)
*
|
2005-06-14 |
2011-10-28 |
Taigen Biotechnology Co Ltd |
Pyrimidine compounds
|
|
KR101415426B1
(ko)
*
|
2005-09-27 |
2014-07-04 |
아이알엠 엘엘씨 |
디아릴아민-함유 화합물 및 조성물, 및 ｃ-ｋｉｔ 수용체의조절제로서의 그의 용도
|
|
AR056556A1
(es)
|
2005-09-30 |
2007-10-10 |
Astrazeneca Ab |
Imidazo(1,2-a)piridina con actividad antiproliferacion celular
|
|
WO2007062417A1
(en)
*
|
2005-11-28 |
2007-05-31 |
Kalypsys, Inc. |
Methods of preparing 2-imidazol-1-yl-4-methyl-6-pyrrolidin-2-yl-pyrimidine and 4-(1-alkylpyrrolidin-2-yl)-2-(1h-imidazol-1-yl)-6-methylpyrimidine derivatives
|
|
EP1988075B1
(en)
|
2006-02-20 |
2012-01-25 |
Astellas Pharma Inc. |
Pyrrole derivative or salt thereof
|
|
AR061185A1
(es)
|
2006-05-26 |
2008-08-13 |
Chugai Pharmaceutical Co Ltd |
Compuestos heterociclicos como inhibidores de hsp90. composiciones farmaceuticas.
|
|
US20100093776A1
(en)
*
|
2006-12-22 |
2010-04-15 |
Novartis Ag |
Organic Compounds and Their Uses
|
|
MX2009008756A
(es)
|
2007-03-01 |
2009-08-27 |
Chugai Pharmaceutical Co Ltd |
Compuesto macrociclico.
|
|
CN101678215B
(zh)
|
2007-04-18 |
2014-10-01 |
辉瑞产品公司 |
用于治疗异常细胞生长的磺酰胺衍生物
|
|
KR101294731B1
(ko)
*
|
2007-06-04 |
2013-08-16 |
삼성디스플레이 주식회사 |
어레이 기판, 이를 갖는 표시패널 및 이의 제조방법
|
|
US8293757B2
(en)
*
|
2007-08-22 |
2012-10-23 |
Irm Llc |
5-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
|
|
RU2378278C2
(ru)
*
|
2008-01-24 |
2010-01-10 |
Андрей Александрович Иващенко |
ЗАМЕЩЕННЫЕ 3-СУЛЬФОНИЛ-[1,2,3]ТРИАЗОЛО[1,5-a]ПИРИМИДИНЫ-АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ
|
|
KR20100137473A
(ko)
|
2008-02-19 |
2010-12-30 |
아돌로 코포레이션 |
동통 치료를 위한 벨록세핀, 이의 거울상이성질체, 및 이의 유사체
|
|
DK2268635T3
(en)
|
2008-04-21 |
2015-09-14 |
Taigen Biotechnology Co Ltd |
Heterocyclic Compounds
|
|
MX2011012343A
(es)
*
|
2009-05-19 |
2011-12-14 |
Dow Agrosciences Llc |
Compuestos y metodos para controlar hongos.
|
|
PH12012501556A1
(en)
|
2009-12-30 |
2012-10-22 |
Arqule Inc |
Substituted naphthalenyl-pyrimidine compounds
|
|
CN102786512A
(zh)
|
2012-05-31 |
2012-11-21 |
中国人民解放军军事医学科学院毒物药物研究所 |
N-芳基不饱和稠环叔胺类化合物及其制备方法和抗肿瘤应用
|
|
JP6779867B2
(ja)
*
|
2014-06-13 |
2020-11-04 |
ユマ セラピューティクス，インコーポレーテッド |
ピリミジン化合物およびその使用方法
|
|
CN104725322B
(zh)
*
|
2015-02-16 |
2017-05-24 |
同济大学 |
一种2‑胺基嘧啶类化合物及其制备方法
|
|
CA2984586C
(en)
|
2015-04-29 |
2021-02-16 |
Guangdong Zhongsheng Pharmaceutical Co., Ltd. |
Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor
|
|
RU2605265C1
(ru)
*
|
2015-10-06 |
2016-12-20 |
федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФА Минздрава России) |
Анальгезирующее и противовоспалительное средство на основе 5-бутил-6-гидрокси-2-метилпиримидин-4(3h)-она
|
|
MX383920B
(es)
|
2016-05-26 |
2025-03-14 |
Recurium Ip Holdings Llc |
Compuestos inhibidores de egfr.
|
|
WO2019079369A1
(en)
|
2017-10-19 |
2019-04-25 |
Effector Therapeutics, Inc. |
BENZIMIDAZOLE INDOLE INHIBITORS OF MNK1 AND MNK2
|
|
CN108904503B
(zh)
*
|
2018-07-02 |
2021-09-28 |
陕西科技大学 |
6-氯-5-硝基-2,4-二氨基嘧啶在治疗慢性粒细胞白血病药物中的应用
|
|
TWI855088B
(zh)
*
|
2019-06-06 |
2024-09-11 |
美商阿克思生物科學有限公司 |
製備胺基嘧啶化合物的方法
|
|
TWI782504B
(zh)
*
|
2020-05-08 |
2022-11-01 |
美商美國禮來大藥廠 |
(三氟甲基)嘧啶-2-胺化合物
|
|
CN114907273B
(zh)
*
|
2022-06-09 |
2025-02-18 |
乐威医药（江苏）股份有限公司 |
2-氨基嘧啶-6-芳基化合物的制备方法
|